# Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage

> **NCT02330094** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 16 (actual)

## Conditions studied

- Aneurysmal Subarachnoid Hemorrhage

## Interventions

- **DRUG:** Gabapentin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02330094
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2017-09-01
- **Final completion:** 2017-09-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02330094

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02330094, "Gabapentin for Headache in Aneurysmal Subarachnoid Hemorrhage". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02330094. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*